The approval came days before the FDA’s expected deadline and makes this the only PD-1 inhibitor approved for resectable ...

Opdivo (nivolumab) for resectable non-small cell lung cancer (NSCLC) and no known epidermal growth factor receptor (EGFR) ...

The checkpoint inhibitor is now approved, based on CheckMate 77T findings, for neoadjuvant/adjuvant use in patients with ...

The FDA has approved Opdivo (nivolumab) as neoadjuvant and adjuvant treatment for adults with resectable NSCLC.

Bristol Myers Squibb has received FDA approval for Opdivo (nivolumab) combined with chemotherapy as a perioperative treatment ...

In 2023, BMS received a similar approval across the pond. The National Institute for Health and Care Excellence (NICE) cleared Opdivo (nivolumab) for use with platinum-based chemo to reduce the size ...

BriaCell Therapeutics announced that its Bria-IMT cell therapy, plus an immune checkpoint inhibitor regimen, achieved ...

Illumina, Inc. , a global leader in DNA sequencing and array-based technologies, announced that after 11 years of service, Charles "Chuck" Dadswell will step down as General Counsel and Secretary on ...

Sun Life U.S. and DentaQuest, part of Sun Life U.S., are supporting relief efforts in the states most severely impacted by Hurricane Helene. The support will go to multiple organizations, including ...

For mesothelioma, combinations of Opdivo (nivolumab) and Yervoy (ipilimumab) may be part of the treatment plan if you're between stage 2 and stage 4 mesothelioma. The most critical way to prevent ...

External affairs minister S Jaishankar meets with Sajith Premadasa, Sri Lanka's opposition leader, during his visit to Colombo. Jaishankar is the first foreign dignitary to visit since the NPP ...

Blasts Shake Beirut as Israel Targets Hezbollah Leaders, Officials Say Israeli officials said planes bombed a bunker where senior Hezbollah officials were meeting, including the presumed successor ...